Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-10-19 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BERGUES (59380), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DOUCEMENT : revenue, balance sheet and financial ratios
PHARMACIE DOUCEMENT is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BERGUES (59380),
this company of category PME
shows in 2023 a net income positive of 200 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DOUCEMENT (SIREN 814238259)
Indicator
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
199 715 €
200 727 €
155 804 €
129 501 €
133 336 €
101 762 €
-13 817 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DOUCEMENT generates positive net income of 200 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
199 715 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
23.429%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
73.346%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
Debt ratio
411.491
242.492
149.9
102.578
70.506
32.901
23.429
Financial autonomy
17.001
25.076
35.051
43.924
52.358
66.824
73.346
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
23.432023
2020
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-13 pts over 3 years
In 2023, the debt ratio of PHARMACIE DOUCEMENT (23.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
73.35%2023
2020
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent+12 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DOUCEMENT (73.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 522.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
Liquidity ratio
171.957
177.953
222.011
269.908
318.551
425.018
522.033
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
522.032023
2020
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent
In 2023, the liquidity ratio of PHARMACIE DOUCEMENT (522.03) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DOUCEMENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DOUCEMENT is estimated at
2 356 532 €
(range 1 433 120€ - 3 312 755€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1433k€2356k€3312k€
2 356 532 €Range: 1 433 120€ - 3 312 755€
NAF 5 année 2023
Valuation method used
Net Income Multiple
199 715 €
×
11.8x
=2 356 532 €
Range: 1 433 120€ - 3 312 756€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DOUCEMENT with other companies in the same sector:
Frequently asked questions about PHARMACIE DOUCEMENT
What is the revenue of PHARMACIE DOUCEMENT ?
The revenue of PHARMACIE DOUCEMENT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DOUCEMENT profitable?
Yes, PHARMACIE DOUCEMENT generated a net profit of 200 k€ in 2023.
Where is the headquarters of PHARMACIE DOUCEMENT ?
The headquarters of PHARMACIE DOUCEMENT is located in BERGUES (59380), in the department Nord.
Where to find the tax return of PHARMACIE DOUCEMENT ?
The tax return of PHARMACIE DOUCEMENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DOUCEMENT operate?
PHARMACIE DOUCEMENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart